Short answer: Dihydrocodeine can be prescribed for regular daily use in some situations, but it should only be taken exactly as directed by the prescriber. The appropriate schedule and length of treatment depend on why it is being used, the formulation, the dose and the individual patient.
The most important issue with daily or prolonged opioid use is not simply whether a dose is taken every day, but whether the treatment is still helping and whether tolerance, dependence, side effects or other harms are developing. UK safety guidance warns that prolonged opioid use can lead to dependence and, in some people, addiction even at therapeutic doses.
Yes, in some cases – but only according to the prescription. A daily schedule may be appropriate for some patients, while others may need dihydrocodeine only for a short period. “Every day” does not mean everyone should use the same dose or timing.
NHS guidance explains that standard and slow-release dihydrocodeine have different dosing schedules. This means the safe frequency depends on the formulation and the instructions issued by the prescriber. Do not create your own dosing schedule or increase the dose because pain feels worse.
There is no single frequency that is correct for every dihydrocodeine product or every patient. The frequency depends on the formulation and prescription, so the medicine label and prescriber’s instructions should be followed exactly.
This guide does not provide an alternative dosing schedule because the goal is to explain regular and long-term use safely, not to replace individual prescribing advice.
There is no universal “safe number of days” that applies to everyone. The duration depends on the reason for treatment. After an operation or injury, it may only be needed for a short time; some people with severe or long-term illness may be prescribed it for longer with ongoing review.
The NHS advises that people who have been taking dihydrocodeine for more than a few weeks should not stop it without speaking to their doctor first, because physical dependence and withdrawal symptoms can develop.
For chronic primary pain, the position is different. NICE recommends not initiating opioids for chronic primary pain because evidence of benefit is lacking and there is a risk of harm and dependence. Chronic primary pain is not the same as every form of chronic pain, so the underlying diagnosis matters.
If your question is specifically about back pain rather than regular use in general, read our separate guide: Dihydrocodeine for lower back pain: what you need to know
The main concerns with prolonged opioid use are tolerance, physical dependence, addiction, withdrawal and, in some patients, increased sensitivity to pain. These risks are why long-term treatment should be reviewed rather than simply continued or increased without medical advice.
Tolerance means the same dose may feel less effective over time. If pain control is worsening or you feel you need a higher dose, that is a reason for a medication review – not a reason to increase the dose yourself.
Physical dependence can develop even when an opioid is taken exactly as prescribed. It means the body has adapted to the medicine and withdrawal symptoms may occur if treatment is stopped abruptly.
Dependence and addiction are not the same, but prolonged opioid use can lead to addiction in some people. The MHRA advises that this can occur even at therapeutic doses, with higher risk in some people, including those with a current or past substance-use disorder or certain mental-health conditions.
Long-term opioid use can sometimes be associated with hyperalgesia, which means increased sensitivity to pain. If pain appears to be worsening despite continued opioid treatment, the prescriber may need to review the medicine rather than automatically increase it.
Regular use can also make ongoing side effects more important to monitor. Common effects can include constipation, nausea or vomiting and drowsiness. More serious opioid toxicity can involve breathing problems. This article does not attempt to duplicate a full side-effects guide; the point here is that persistent or worsening effects during daily use are a reason for clinical review.
No – not if you have been taking it regularly for more than a short period without first getting medical advice. Stopping suddenly can trigger withdrawal symptoms, so the dose may need to be reduced gradually.
The MHRA advises slow tapering at the end of opioid treatment to reduce withdrawal risk. The pace of reduction is individual and can take weeks or, from higher doses, sometimes longer. Do not create a tapering plan without your prescriber.
A review is appropriate whenever the balance between benefit and harm may have changed. Speak to the prescriber or pharmacist if any of the following applies:
These signs do not automatically mean the medicine must be stopped, but they do mean the treatment plan should be reviewed rather than changed without professional advice.
It can be appropriate for some patients when there is a clear clinical reason, the medicine is taken exactly as prescribed, and the treatment is reviewed when needed. The longer an opioid is used, the more important it becomes to check that it is still providing meaningful benefit without unacceptable harm.
For more evidence-based medicine information, visit the Forever Care Meds Medicine Guides.
| Medication safety reminder Questions about your prescription, long-term use or side effects? Speak to your prescriber or pharmacist before changing your dose or stopping regular dihydrocodeine. |
